搜索临床试验以:(177Lu-DOTAOTyr3)Octreotate
总计460个结果
-
University of Warmia and MazuryStowarzyszenie Pacjentów i Osób Wspierających Chorych na Guzy Neuroendokrynne未知
-
Peter MacCallum Cancer Centre, Australia招聘中
-
OHSU Knight Cancer InstituteNovartis; Oregon Health and Science University尚未招聘
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)撤销转移性肾上腺嗜铬细胞瘤 | III 期甲状腺髓样癌 AJCC v8 | IV 期甲状腺髓样癌 AJCC v8 | 局部晚期肾上腺嗜铬细胞瘤 | 局部晚期副神经节瘤 | 转移性副神经节瘤 | 转移性甲状旁腺癌 | 垂体癌 | 生长抑素受体阳性 | IVA 期甲状腺髓样癌 AJCC v8 | IVB 期甲状腺髓样癌 AJCC v8 | IVC 期甲状腺髓样癌 AJCC v8 | 不可切除的肾上腺嗜铬细胞瘤 | 不可切除的副神经节瘤美国
-
Ipsen终止胃癌 | 大肠癌 | 骨癌 | 头颈部鳞状细胞癌 | 晚期癌症 | 复发性疾病 | 胰腺导管腺癌 | 转移性肿瘤美国, 法国, 比利时, 瑞士, 荷兰
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Adenoid Cystic Carcinoma Research Foundation; Progenics Pharmaceuticals, Inc.尚未招聘
-
Telix International Pty Ltd尚未招聘
-
Peking University尚未招聘
-
Advanced Accelerator Applications完全的小肠类癌 | 神经内分泌肿瘤美国, 英国, 意大利, 比利时, 法国, 德国, 葡萄牙, 西班牙
-
Peter MacCallum Cancer Centre, AustraliaEndocyte; Movember Foundation; Medical Research Future Fund; E.J. Whitten Foundation Prostate Cancer...主动,不招人
-
Peking Union Medical College HospitalNational Institute for Biomedical Imaging and Bioengineering (NIBIB)招聘中
-
Affiliated Hospital of Jiangnan University尚未招聘
-
Peking Union Medical College Hospital完全的
-
The First Affiliated Hospital of Xiamen University招聘中
-
Advanced Accelerator Applications批准上市
-
Debiopharm International SA招聘中胰腺导管腺癌 (PDAC) | 结直肠癌 (CRC) | 透明细胞肾细胞癌 (ccRCC)法国, 澳大利亚
-
Spago Nanomedical AB招聘中
-
Nicholas Fidelman, MDMerck Sharp & Dohme LLC; BTG International Inc.主动,不招人
-
Nantes University Hospital尚未招聘
-
Advanced Accelerator Applications终止
-
University Hospital of Ferrara招聘中
-
Istituto Scientifico Romagnolo per lo Studio e...招聘中
-
Istituto Scientifico Romagnolo per lo Studio e...主动,不招人
-
The First Affiliated Hospital of Xiamen University招聘中177Lu-DOTA-FAPI | 68Ga-DOTA-FAPI | 诊疗中国
-
Centre Georges Francois Leclerc尚未招聘